# Selection of a Protective T Cell-based HIV-1/FIV Vaccine

> **NCT02389595** · — · ACTIVE_NOT_RECRUITING · sponsor: **University of Florida** · enrollment: 270 (estimated)

## Conditions studied

- HIV

## Interventions

- **OTHER:** HIV positive subjects
- **OTHER:** Non-infected control subjects

## Key facts

- **NCT ID:** NCT02389595
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-05
- **Primary completion:** 2028-05
- **Final completion:** 2028-05
- **Target enrollment:** 270 (ESTIMATED)
- **Last updated:** 2025-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02389595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02389595, "Selection of a Protective T Cell-based HIV-1/FIV Vaccine". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02389595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*